Literature DB >> 17050166

ROS and protein oxidation in early stages of cytotoxic drug induced apoptosis.

Karen England1, Carolyn O Driscoll, Thomas G Cotter.   

Abstract

Cytotoxic drugs induce cell death through induction of apoptosis. This can be due to activation of a number of cell death pathways. While the downstream events in drug induced cell death are well understood, the early events are less clear. We therefore used a proteomic approach to investigate the early events in apoptosis induced by a variety of drugs in HL60 cells. Using 2D-gel electrophoresis, we were able to identify a number of protein changes that were conserved between different drug treatments. Identification of post-translational modifications (PTM) responsible for these proteome changes revealed an increase in protein oxidation in drug treated cells, as well as changes in protein phosphorylation. We demonstrate an accumulation of oxidised proteins within the ER, which lead to ER stress and calcium release and may result in the induction of apoptosis. This study demonstrates the importance of ROS mediated protein modifications in the induction of the early stages of apoptosis in response to chemotherapeutic drug treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17050166     DOI: 10.1080/10715760600838209

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  14 in total

1.  A novel approach for in vivo measurement of mouse red cell redox status.

Authors:  Xiuling Xu; Katharina von Löhneysen; Katrin Soldau; Deborah Noack; Andrew Vu; Jeffrey S Friedman
Journal:  Blood       Date:  2011-08-10       Impact factor: 22.113

2.  Quantitative proteomics: assessing the spectrum of in-gel protein detection methods.

Authors:  Victoria J Gauci; Elise P Wright; Jens R Coorssen
Journal:  J Chem Biol       Date:  2010-06-19

3.  Cytotoxic and apoptotic effects of synthetic benzochromene derivatives on human cancer cell lines.

Authors:  Asma Kheirollahi; Mahboobeh Pordeli; Maliheh Safavi; Sara Mashkouri; M Reza Naimi-Jamal; Sussan Kabudanian Ardestani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-09-27       Impact factor: 3.000

4.  Cobalt chloride decreases fibroblast growth factor-21 expression dependent on oxidative stress but not hypoxia-inducible factor in Caco-2 cells.

Authors:  Yanlong Liu; Chunhong Wang; Yuhua Wang; Zhenhua Ma; Jian Xiao; Craig McClain; Xiaokun Li; Wenke Feng
Journal:  Toxicol Appl Pharmacol       Date:  2012-08-10       Impact factor: 4.219

5.  Tracking cellular stress with labeled FMAU reflects changes in mitochondrial TK2.

Authors:  Omid S Tehrani; Kirk A Douglas; Jawana M Lawhorn-Crews; Anthony F Shields
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-02-12       Impact factor: 9.236

6.  Induction of ER Stress-Mediated Apoptosis by α-Lipoic Acid in A549 Cell Lines.

Authors:  Jong In Kim; Sung-Rae Cho; Chang Min Lee; Eok-Sung Park; Ki Nyun Kim; Hyung Chul Kim; Hae Young Lee
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2012-02-07

7.  CD44+ gastric cancer cells with stemness properties are chemoradioresistant and highly invasive.

Authors:  Mao Sun; Wei Zhou; Yun-Yun Zhang; Dong-Lin Wang; Xiao-Ling Wu
Journal:  Oncol Lett       Date:  2013-03-26       Impact factor: 2.967

Review 8.  Mechanisms of radiation toxicity in transformed and non-transformed cells.

Authors:  Ronald-Allan M Panganiban; Andrew L Snow; Regina M Day
Journal:  Int J Mol Sci       Date:  2013-07-31       Impact factor: 5.923

9.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

10.  Endoplasmic reticulum stress is involved in the response of human laryngeal carcinoma cells to Carboplatin but is absent in Carboplatin-resistant cells.

Authors:  Anamaria Brozovic; Lidija Vuković; Darija Stupin Polančac; Istvan Arany; Beate Köberle; Gerhard Fritz; Zeljka Fiket; Dragomira Majhen; Andreja Ambriović-Ristov; Maja Osmak
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.